128 related articles for article (PubMed ID: 19268328)
1. [Treatment with rituximab in a patient with mononeuritis multiplex asocciated to hepatitis C infection with mixed cryoglobulinemia].
Ivorra J; Muñoz S; Román-Ivorra J; Beltrán E
Med Clin (Barc); 2009 Mar; 132(11):444-5. PubMed ID: 19268328
[No Abstract] [Full Text] [Related]
2. Refractory Mononeuritis Multiplex Due to Hepatitis C Infection and Cryoglobulinemia: Efficient Response to Rituximab.
Soares CN
Neurologist; 2016 May; 21(3):47-8. PubMed ID: 27119277
[TBL] [Abstract][Full Text] [Related]
3. [Hepatitis associated cryoglobulinemia].
Pischke S; Cornberg M; Manns MP
Internist (Berl); 2008 Mar; 49(3):297-304. PubMed ID: 18327517
[TBL] [Abstract][Full Text] [Related]
4. Rituximab for the treatment of glomerulonephritis in hepatitis C associated cryoglobulinaemia.
Korte MR; van Heerde MJ; de Man RA; Betjes MH
Neth J Med; 2008 Jan; 66(1):27-30. PubMed ID: 18219065
[TBL] [Abstract][Full Text] [Related]
5. Should rituximab be the rescue therapy for refractory mixed cryoglobulinemia associated with hepatitis C?
Ahmed MS; Wong CF
J Nephrol; 2007; 20(3):350-6. PubMed ID: 17557269
[TBL] [Abstract][Full Text] [Related]
6. Acute wrist and foot drop associated with hepatitis C virus related mixed cryoglobulinemia: rapid response to treatment with rituximab.
Uppal R; Charles E; Lake-Bakaar G
J Clin Virol; 2010 Jan; 47(1):69-71. PubMed ID: 19892591
[TBL] [Abstract][Full Text] [Related]
7. Rituximab monotherapy, rather than rituximab plus antiviral drugs, for initial treatment of severe hepatitis C virus-associated mixed cryoglobulinemia syndrome: comment on the article by Terrier et al.
De Vita S; Quartuccio L
Arthritis Rheum; 2010 Mar; 62(3):908-9; author reply 909. PubMed ID: 20131242
[No Abstract] [Full Text] [Related]
8. Rituximab-responsive cryoglobulinemic glomerulonephritis in a patient with autoimmune hepatitis.
Evans JT; Shepard MM; Oates JC; Self SE; Reuben A
J Clin Gastroenterol; 2008 Aug; 42(7):862-3. PubMed ID: 18458643
[No Abstract] [Full Text] [Related]
9. Cryoglobulin-induced cardiomyopathy.
Karras A; Potier L; Reboux AH; Coldea N; Perdrix L; Jacquot C; Mousseaux E
J Am Coll Cardiol; 2010 Feb; 55(7):e13. PubMed ID: 20170783
[No Abstract] [Full Text] [Related]
10. Efficacy and risk of rituximab in type II mixed cryoglobulinemia: a significant case report.
Massari M; Catania A; Magnani G
Dig Liver Dis; 2007 Sep; 39 Suppl 1():S134-5. PubMed ID: 17936216
[No Abstract] [Full Text] [Related]
11. Treatment of type II cryoglobulinemia associated with hepatitis C with rituximab.
Pekow J; Chung RT
J Clin Gastroenterol; 2006; 40(5):450. PubMed ID: 16721231
[No Abstract] [Full Text] [Related]
12. Essential mixed cryoglobulinemia type III with leukocytoclastic vasculitis: remission by rituximab.
Baerlecken NT; Schmidt RE
Clin Rheumatol; 2013 Mar; 32 Suppl 1():S19-20. PubMed ID: 20213127
[TBL] [Abstract][Full Text] [Related]
13. Rituximab for the treatment of type II mixed cryoglobulinemia.
Zaja F; De Vita S; Russo D; Michelutti A; Fanin R; Ferraccioli G; Baccarani M
Arthritis Rheum; 2002 Aug; 46(8):2252-4; author reply 2254-5. PubMed ID: 12209536
[No Abstract] [Full Text] [Related]
14. Restoration of peripheral immune homeostasis after rituximab in mixed cryoglobulinemia vasculitis.
Saadoun D; Rosenzwajg M; Landau D; Piette JC; Klatzmann D; Cacoub P
Blood; 2008 Jun; 111(11):5334-41. PubMed ID: 18292291
[TBL] [Abstract][Full Text] [Related]
15. [Twenty-seven years' activities of the French vasculitis study group (FVSG)].
Guillevin L
Rev Med Interne; 2007 Dec; 28 Suppl 4():S263-5. PubMed ID: 18029060
[No Abstract] [Full Text] [Related]
16. Treatment of cryoglobulinemia associated peripheral neuropathy with rituximab.
Cai FZ; Ahern M; Smith M
J Rheumatol; 2006 Jun; 33(6):1197-8. PubMed ID: 16755669
[TBL] [Abstract][Full Text] [Related]
17. Rapidly fatal Acanthamoeba encephalitis and treatment of cryoglobulinemia.
Meersseman W; Lagrou K; Sciot R; de Jonckheere J; Haberler C; Walochnik J; Peetermans WE; van Wijngaerden E
Emerg Infect Dis; 2007 Mar; 13(3):469-71. PubMed ID: 17552103
[TBL] [Abstract][Full Text] [Related]
18. Clinical spectrum, treatment, and outcome of patients with type II mixed cryoglobulinemia without evidence of hepatitis C infection.
Foessel L; Besancenot JF; Blaison G; Magy-Bertrand N; Jaussaud R; Etienne Y; Maurier F; Audia S; Martin T
J Rheumatol; 2011 Apr; 38(4):716-22. PubMed ID: 21239761
[TBL] [Abstract][Full Text] [Related]
19. Treatment for glomerulonephritis in HCV-associated mixed cryoglobulinaemia--anti-viral therapy vs rituximab.
Bruchfeld A; Saadoun D; Cacoub P
Rheumatology (Oxford); 2006 Jun; 45(6):783-4; author reply 784-5. PubMed ID: 16679341
[No Abstract] [Full Text] [Related]
20. Life-threatening infections following rituximab therapy in renal transplant patients with mixed cryoglobulinemia.
Basse G; Ribes D; Kamar N; Esposito L; Rostaing L
Clin Nephrol; 2006 Nov; 66(5):395-6. PubMed ID: 17140171
[No Abstract] [Full Text] [Related]
[Next] [New Search]
